Scientists have linked a specific protein to the development of post-viral infection asthma, which is the first step in generating a novel type of asthma therapy designed to prevent its development in young children.
Asthma is a chronic disease of the airways that affects more than 300 million people worldwide. It is the number one illness leading to school absences in children, and accounts for more than 1.8 million emergency room visits annually. There is no cure; all current therapies focus on providing symptomatic relief and reducing the number and severity of attacks.
Preventing Development of Asthma With Psychedelic Drug
A psychedelic drug, (R)-DOI, may help prevent asthma development. Research led by Charles Nicholas has found that this drug prevents the development of allergic asthma in a mouse model.
Advertisement
Lead researcher Mitchell H. Grayson said that understanding the molecular mechanisms by which asthma develops and establishes itself as a chronic disease is key to elucidating alternative and potentially curative therapies.
The researchers previously found evidence linking a human chemokine (protein) called CCL28 to the development of chronic asthma. However, this study is the first that examines structural analysis and its impact on disease development.
![Millions in Britain Who are Receiving Asthma Treatment may Have Been Wrongly Diagnosed]( "Millions in Britain Who are Receiving Asthma Treatment may Have Been Wrongly Diagnosed")
The National Institute for Health and Care Excellence (NICE) has found that more than 1 million people in Britain who are receiving treatment for asthma may have been wrongly diagnosed.
Lead researcher Brian F. Volkman said that they found that even in the absence of a viral infection, CCL28 can play a role in the induction of asthma pathology, when the protein is natively folded. If unfolded, it does not.
Volkman continued that they propose that by exploiting the unique structural features of CCL28, potent and specific CCL28 inhibitors may be developed. This work is the first step in generating a novel type of asthma therapy that may have the power to prevent development of post-viral asthma in young children.
The findings are published in the Journal of Biological Chemistry.
Source: ANI
Millions in Britain Who are Receiving Asthma Treatment may Have Been Wrongly Diagnosed
The National Institute for Health and Care Excellence (NICE) has found that more than 1 million people in Britain who are receiving treatment for asthma may have been wrongly diagnosed.
Advertisement
Lead researcher Brian F. Volkman said that they found that even in the absence of a viral infection, CCL28 can play a role in the induction of asthma pathology, when the protein is natively folded. If unfolded, it does not.
Volkman continued that they propose that by exploiting the unique structural features of CCL28, potent and specific CCL28 inhibitors may be developed. This work is the first step in generating a novel type of asthma therapy that may have the power to prevent development of post-viral asthma in young children.
The findings are published in the Journal of Biological Chemistry.
Source: ANI
The Changing Face of Pediatric Asthma
It is a long-standing belief that city dwellers suffer disproportionately from asthma.
Advertisement
 Allergic Asthma Response-Triggering Cellular Pathway IdentifiedA novel signalling pathway critical to the immune response of cells associated with the initiation of allergic asthma has been identified by researchers at the University of California. | Advertisement
|
Advertisement
Recommended Reading
Latest Respiratory Disease News
Increased use of tobacco boosts the risk of catching tuberculosis, heightens the risk of recurrent TB as well, say experts.
In South Africa, the cases of tuberculosis continue to rise making it as the primary cause of ill health and mortality.
Among patients with influenza, unnecessary prescription of antibiotics is found to have a significant impact on the growing threat of antimicrobial resistance.
India is left with 32 months (2025) to end tuberculosis and Nigeria is left with 92 months (2030) respectively.
Globally every year tuberculosis affects more than 10 million people. India contributes to 30% of the global tuberculosis burden.